Where are you calling from? pharmaplus This whole article reads strangely to me. First of all, unless Popova is benefiting from public funds or actively ripping people off, this doesn’t really qualify as news. The copyright question does, and I don’t see why that isn’t pursued. As it is, it’s just one person having a problem with her making money at what she does.